
X
NICE recommends Eisai’s kidney cancer combination
https://pharmaphorum.com/news/nice-recommends-eisais-kidney-cancer-combination/
Japanese pharma getting frustrated with NICE
Regulator hopes move will combat illegal online trade
ABPI and others concerned over potential disruption to supplies
NICE rejects drug after finding gap in clinical data
Big pharma investment “very important”, says peer.